Monovision ideal for most presbyopes

Article

Surgical monovision is an attractive option for presbyopes seeking refractive surgery and wanting freedom from glasses and contact lenses, according to Mark Mannis, MD, University of California, USA.

Surgical monovision is an attractive option for presbyopes seeking refractive surgery and wanting freedom from glasses and contact lenses, according to Mark Mannis, MD, University of California, USA.

Dr Mannis presented results of a study that enrolled 87 subjects, aged 40 years of age or older, undergoing LASIK monovision. Preoperative refractive errors included spherical myopia, myopia with astigmatism, hyperopia, hyperopia with astigmatism and mixed astigmatism. Thirty-five patients had a contact lens trial preoperatively.

Postoperative mean spherical equivalent (SE) was 0.02 D in the distance eye and -1.27 D in the near eye. Overall, 98% of patients were satisfied with the procedure. Two patients underwent monovision reversal; neither had a preoperative contact lens trial. However, 31 eyes underwent LASIK enhancement, which most often was performed for the distance eye.

Dr Mannis commented, "practitioners should expect long chair times preoperatively and a relatively high enhancement rate postoperatively because even small amounts of astigmatism may require correction. In addition to careful screening and counselling, we also recommend a presurgical contact lens trial for all patients, suggest a minimum three-week acclimatization period after surgery, and use of 'glove box' glasses for scoptic conditions. In addition, this method is not recommended for certain patients, including pilots or professional drivers."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.